Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection

Summary

The purpose of the study is to understand how COVID affects the body and why some individuals who contract COVID are still sick for many months after being infected. This condition is called “Long COVID” or “PASC” (post-acute sequelae of SARS-CoV-2). Participants will be 18 years or older. Researchers aim to determine who is at greatest risk of experiencing long-term effects of COVID by studying individuals with and without a history of COVID-19 over several years.

Participants will be asked to answer basic questions (race, ethnic group, sex), in addition to questions about their health, behaviors, medical problems, medications, conditions that may affect the chances of having long-term effects of COVID-19, vaccination status, and any symptoms they may have. Blood, saliva, urine and other samples will also be collected.


Inclusion Criteria

  • INFECTED COHORT -- ADULTS WITH SUSPECTED SARS-COV-2 INFECTION --
  • An adult qualifies as having suspected SARS-CoV-2 infection if meeting criteria a, b or c below:
Show more

Study Location(s)

Beverly

More about this Clinical Trial

Full Title

NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults

Details
Disease Type/Condition

Other

Principal Investigator

Chen, Peter

Age Group

Adult

Phase

N/A

IRB Number

STUDY00001983

ClinicalTrials.gov ID

NCT05172024

Key Eligibility
ClinicalTrials.gov

Contact
Phone
310-423-6252
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?

Details
Disease Type/Condition

Other

Principal Investigator

Chen, Peter

Age Group

Adult

Phase

N/A

IRB Number

RECOVER-S21-01226

ClinicalTrials.gov ID

NCT05172024

Key Eligibility
ClinicalTrials.gov

Contact
Phone
310-423-6252
Email
clinicaltrials@cshs.org
Want to join the study or
learn more?